Cytotoxic/tumor suppressor role of zinc for the treatment of cancer: an enigma and an opportunity

References

• Costello LC, Franklin RB. The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots. Mol. Cancer5, 17 (2006).
   PubMed Web of Science ®Google Scholar
• Franklin RB, Milon B, Feng P, Costello LC. Zinc and zinc transporter in normal prostate function and the pathogenesis of prostate cancer. Front. Biosci.10, 2230–2239 (2005).
   PubMed Web of Science ®Google Scholar
• Costello LC, Franklin RB, Feng P, Tan M, Bagasra O. Zinc and prostate cancer: a critical scientific, medical and public interest issue. Cancer Causes Contr.16, 901–915 (2005).
   PubMed Web of Science ®Google Scholar
• Danielsen A, Steinnes E. A study of some selected trace elements in normal and cancerous tissue by neutron activation analysis. J. Nucl. Med.11, 260–264 (1970).
   PubMed Web of Science ®Google Scholar
• Ebara M, Fukuda H, Hatano R et al. Relationship between copper, zinc and metallothionein in hepatocellular carcinoma and its surrounding liver parenchyma. J. Hepatol.33, 415–422 (2000).
   PubMedGoogle Scholar
• Gurusamy K. Trace element concentration in primary liver cancers – a systematic review. Biol. Trace Elem. Res.118, 191–206 (2007).
   PubMedGoogle Scholar
• Liaw KY, Lee PH, Wu FC, Tsai JS, Lin-Shiau SY. Zinc, copper, and superoxide dismutase in hepatocellular carcinoma. Am. J. Gastroenterol.92, 2260–2263 (1997).
   PubMed Web of Science ®Google Scholar
• Tashiro H, Kawamoto T, Okubo T, Koide O. Variation in the distribution of trace elements in hepatoma. Biol. Trace Elem. Res.95, 49–63 (2003).
   PubMed Web of Science ®Google Scholar
• Tashiro-Itoh T, Ichida T, Matsuda Y et al. Metallothionein expression and concentrations of copper and zinc are associated with tumor differentiation in hepatocellular carcinoma. Liver17, 300–306 (1997).
   PubMedGoogle Scholar
• Al-Ebraheem A, Farquharson MJ, Ryan E. The evaluation of biologically important trace metals in liver, kidney and breast tissue. Appl. Radiat. Isot.67, 470–474 (2009).
   PubMedGoogle Scholar
• Franklin RB, Levy BA, Zou J et al. ZIP14 zinc transporter downregulation and zinc depletion in the development and progression of hepatocellular cancer. J. Gastrointest. Cancer doi:10.1007/s12029-011-9269-x (2011) (Epub ahead of print).
   Google Scholar
• Costello LC, Levy B, Desouki M et al. Decreased zinc and downregulation of ZIP3 zinc uptake transporter in the development of pancreatic adenocarcinoma. Cancer Biol. Ther.12, 297–303 (2011).
   PubMed Web of Science ®Google Scholar
• Lightman A, Brandes JM, Binur N, Drugan A, Zinder O. Use of the serum copper/zinc ratio in the differential diagnosis of ovarian malignancy. Clin. Chem.32, 101–103 (1986).
   PubMed Web of Science ®Google Scholar
• Costello LC, Fensaleu C, Franklin RB. Evidence for operation of the direct zinc ligand exchange mechanism for trafficking, transport, and reactivity of zinc in mammalian cells. J. Inorg. Biochem.105, 589–599 (2011).
   PubMed Web of Science ®Google Scholar
• Mawson CA, Fischer MI. The occurrence of zinc in the human prostate gland. Can. J. Med. Sci.30, 336–339 (1952).
   PubMedGoogle Scholar
• Franklin RB, Feng P, Milon BC et al. hZIP1 zinc uptake transporter downregulation and zinc depletion in prostate cancer. Mol. Cancer4, 32 (2005).
   PubMed Web of Science ®Google Scholar
• Johnson LA, Kanak MA, Kajdacsy-Balla A, Pestaner JP, Bagasra O. Differential zinc accumulation and expression of human zinc transporter 1 (hZIP1) in prostate glands. Methods4, 316–321 (2010).
   Google Scholar
• Cortesi M, Fridman E, Volkov A et al. Clinical assessment of the cancer diagnostic value of prostatic zinc: a comprehensive needle-biopsy study. Prostate68, 994–1006 (2008).
   PubMed Web of Science ®Google Scholar
• Franklin RB, Costello LC. The important role of the apoptotic effects of zinc in the development of cancers. J. Cell Biochem.106, 750–757 (2009).
   PubMed Web of Science ®Google Scholar
• Costello LC, Franklin RB. The genetic/metabolic transformation concept of carcinogenesis. Cancer Metastasis Rev. doi:10.1007/s10555-011-9334-8. (2011) (Epub ahead of print).
   Google Scholar
• Feng P, Li T, Guan Z, Franklin RB, Costello LC. Effect of zinc on prostate tumorigenicity in nude mice. Ann. NY Acad. Sci.1010, 316–320 (2003).
   PubMed Web of Science ®Google Scholar
• Costello LC, Liu L, Zou J, Franklin RB. Evidence for a zinc uptake transporter in human prostate cancer cells which is regulated by prolactin and testosterone. J. Biol. Chem.274, 17499–17504 (1999).
   PubMed Web of Science ®Google Scholar
• Franklin RB, Ma J, Zou J et al. Human Zip1 is a major zinc uptake transporter for accumulation of zinc in prostate cells. J. Inorgan. Biochem.96, 435–442 (2003).
   PubMedGoogle Scholar
• Ding WQ, Liu B, Vaught JL, Yamauchi H, Lind SE. Anticancer activity of the antibiotic clioquinol. Cancer Res.65, 3389–3395 (2005).
   PubMed Web of Science ®Google Scholar
• Vallee BL, Falchuk KH. The biochemical basis of zinc physiology. Physiol. Rev.73, 79–118 (1993).
   PubMed Web of Science ®Google Scholar
• Jayaraman AK, Jayaraman S. Increased level of exogenous zinc induces cytotoxicity and up-regulates the expression of the ZnT-1 zinc transporter gene in pancreatic cancer cells. J. Nutr. Biochem.22, 79–88 (2011).
   PubMed Web of Science ®Google Scholar
• Sliwinski T, Czechowska A, Kolodziejczak M, Jajte J, Wisniewska-Jarosinska M, Blasiak J. Zinc salts differentially modulate DNA damage in normal and cancer cells. Cell Biol. Int.33, 542–547 (2009).
   PubMedGoogle Scholar
• Liang, J Y, Liu YY, Zou J, Franklin RB, Costello LC, Feng P. Inhibitory effect of zinc on human prostatic carcinoma cell growth. Prostate40, 200–207 (1999).
   PubMed Web of Science ®Google Scholar
• Feng P, Li L, Guan ZX, Franklin RB, Costello LC. Direct effect of zinc on mitochondrial apoptogenesis in prostate cells. Prostate52, 311–318 (2002).
   PubMed Web of Science ®Google Scholar
• Feng P, Li T, Guan Z, Franklin RB, Costello LC. The involvement of Bax in zinc-induced mitochondrial apoptogenesis in malignant prostate cells. Mol. Cancer7, 25 (2008).
   PubMed Web of Science ®Google Scholar
• Ku JH, Seo SY, Kwak C, Kim HH. The role of survivin and Bcl-2 in zinc-induced apoptosis in prostate cancer cells. Urol. Oncol. doi:10.1016/j.urolonc.2010.06.001 (2010) (Epub ahead of print).
   PubMedGoogle Scholar
• Park SE, Park JW, Cho YS, Ryu JH, Paick JS, Chun YS. HIF-1alpha promotes survival of prostate cells at a high zinc environment. Prostate67, 1514–1523 (2007).
   PubMedGoogle Scholar
• Yun YJ, Li SH, Cho YS, Park JW, Chun YS. Survivin mediates prostate cell protection by HIF-1alpha against zinc toxicity. Prostate70, 1179–1188 (2010).
   PubMedGoogle Scholar
• Mao X, Schimmer AD. The toxicology of clioquinol. Toxicol. Lett.182, 1–6 (2008).
   PubMed Web of Science ®Google Scholar
• Bareggi SR, Cornelli U. Clioquinol: review of its mechanisms of action and clinical uses in neurodegenerative disorders. CNS Neurosci. Ther. doi:10.1111/j.1755–5949. 2010.00231.x (2010) (Epub ahead of print).
   PubMedGoogle Scholar
• Lemire J, Mailloux R, Appanna VD. Zinc toxicity alters mitochondrial metabolism and leads to decreased ATP production in hepatocytes. J. Appl. Toxicol.28, 175–182 (2008).
   PubMed Web of Science ®Google Scholar
• Xu J, Xu Y, Nguyen Q, Novikoff PM, Czaja MJ. Induction of hepatoma cell apoptosis by c-myc requires zinc and occurs in the absence of DNA fragmentation. Am. J. Physiol.270, G60–G70 (1996).
   Google Scholar
• Donadelli M, Dalla PE, Scupoli MT, Costanzo C, Scarpa A, Palmieri M. Intracellular zinc increase inhibits p53-/- pancreatic adenocarcinoma cell growth by ROS/AIF-mediated apoptosis. Biochim. Biophys. Acta1793, 273–280 (2009).
   PubMedGoogle Scholar
• Bae SN, Lee YS, Kim MY, Kim JD, Park LO. Antiproliferative and apoptotic effects of zinc-citrate compound (CIZAR®) on human epithelial ovarian cancer cell line, OVCAR-3. Gynecol. Oncol.103, 127–136 (2006).
   PubMed Web of Science ®Google Scholar
• Ding WQ, Yu HJ, Lind SE. Zinc-binding compounds induce cancer cell death via distinct modes of action. Cancer Lett.271, 251–259 (2008).
   PubMedGoogle Scholar
• Rizk SL, Sky-Peck HH. Comparison between concentrations of trace elements in normal and neoplastic human breast tissue. Cancer Res.44, 5390–5394 (1984).
   PubMed Web of Science ®Google Scholar
• Santoliquido PM, Southwick HW, Olwin JH. Trace metal levels in cancer of the breast. Surg. Gynecol. Obstet.142, 65–70 (1976).
   PubMedGoogle Scholar
• Margalioth EJ, Schenker JG, Chevion M. Copper and zinc levels in normal and malignant tissues. Cancer52, 868–872 (1983).
   PubMed Web of Science ®Google Scholar
• Farquharson MJ, Al-Ebraheem A, Geraki K, Leek R, Jubb A, Harris AL. Zinc presence in invasive ductal carcinoma of the breast and its correlation with oestrogen receptor status. Phys. Med. Biol.54, 4213–4223 (2009).
   PubMed Web of Science ®Google Scholar
• Lopez V, Foolad F, Kelleher SL. ZnT2-overexpression represses the cytotoxic effects of zinc hyper-accumulation in malignant metallothionein-null T47D breast tumor cells. Cancer Lett.304, 41–51 (2011).
   PubMedGoogle Scholar
• Doerr TD, Prasad AS, Marks SC et al. Zinc deficiency in head and neck cancer patients. J. Am. Coll. Nutr.16, 418–422 (1997).
   PubMed Web of Science ®Google Scholar
• Franklin RB, Costello LC. Zinc as an anti-tumor agent in prostate cancer and in other cancers. Arch. Biochem. Biophys.463, 211–217 (2007).
   PubMed Web of Science ®Google Scholar